bmiMD vs. Noom Med: prices, fine print, and the honest verdict

Tirzepatide pricing

bmiMD does not offer tirzepatide. Noom Med does not offer tirzepatide.

Semaglutide pricing

On semaglutide, Noom Med wins at $199 versus $289 all-in — $90/mo apart. bmiMD: Semaglutide runs $289 a month all-in. Noom Med: Semaglutide runs $199 a month all-in — capped at 0.6 mg, a quarter of the trial dose.

Transparency

bmiMD: Source-verified (verified 2026-08-08); dispensing pharmacy not publicly named. Noom Med: Source-verified (verified 2026-08-08); names its pharmacy — Tailor Made Compounding (named). In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

bmiMD: none stated; not published. Noom Med: 12-week cycles; 12-week billing cycles.

The semaglutide board

On semaglutide, Noom Med prices at $199 against $289 all-in. Both sit against a verified field floor of $133 and Wegovy's flat $349 brand rate; dual-molecule pricing also sets each program's internal switch cost when a plateau raises the tirzepatide question.

The five normalizations, applied to this pair

1 · All-in, not advertised. bmiMD publishes no figure to normalize; Noom Med publishes no figure to normalize. 4 · Evidence tiered. bmiMD: source-verified, read 2026-08-08; Noom Med: source-verified, read 2026-08-08. 5 · Pharmacy weighed. bmiMD names no pharmacy; Noom Med names Tailor Made Compounding (named) — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

bmiMD: no membership — the medication figure is the billed figure; not published; commitment: none stated. Noom Med: no membership — the medication figure is the billed figure; 12-week billing cycles; commitment: 12-week cycles. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

bmiMD carries source-verified pricing (last read 2026-08-08); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Noom Med carries source-verified pricing (last read 2026-08-08); pharmacy disclosure is its strong suit — Tailor Made Compounding (named), named 503A/503B partner. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

The switch mechanics are symmetric: new intake, new script, new pharmacy, old plan cancelled in writing. Budget a shipping-gap week, confirm the destination program's price at your current dose (not its starter figure), and if the move is also a molecule change, loop the prescriber in per the switching guide.

Refills, shipping, and the week-to-week reality

Logistics decide more churn than price does, so put them on the record: bmiMD: shipping included; consultation included; async visit model. Noom Med: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick bmiMD if its published terms happen to fit your state, format, or timing. Pick Noom Med if the semaglutide line is cheaper here; a named pharmacy is non-negotiable for you. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

Widen the frame one step and the strongest adjacent options are NexLife at $215 (flat, no membership, named pharmacy); Yucca Health at $258 (flat, no membership); IVIM Health at $278 (dose-scaled, $75 membership included) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.